Effect of a Novel Antibiotic, Heliquinomycin, on DNA Helicase and Cell Growth resistant P388 cell lines were inhibited at similar concentrations. Heliquinomycin inhibited both DNA and RNA synthesis in cell culture but did not inhibit protein synthesis. HeLa S3 cells were arrested at the G2/M phase by heliquinomycin. These studies suggest that heliquinomycin is a selective inhibitor of a cellular DNA helicase and in turn, inhibits growth of tumor cell lines.
Cellular DNA replication and repair are catalyzed by a complex of enzymes which can be measured using the simian virus SV40 cell-free DNA replication and repair identify inhibitors of DNA polymerase, proliferating cell nuclear antigen (PCNA) and the ssDNA binding proteins. One of the binding proteins, the large T antigen, is a viral protein encoded by SV40 which displays DNA helicase activity4 In this context, we identified a novel human DNA helicase inhibitor named heliquinomycin (Fig. 1) . In this paper, we report the inhibitory activities of heliquinomycin on DNA helicase and on tumor cell growth. were subjected to 1% agarose gel electrophoresis with Tris-acetate-EDTA buffer.
DNA repair assay was assessed using the method reported by SUGASAWA et al.3). The reaction mixture subjected to 1% agarose gel electrophoresis with Trisacetate-EDTA buffer as desacrived previously3).
In both test system, the incorporation of radiolabeled nucleotide into DNA was determined by Fuji BAS2000 Bio-imaging Analyzer (Fuji Photo Film Co., LTD. Tokyo, Japan). (Fig. 4A) . The G2/M phase arrest was confirmed with cells synchronized at G1/S after aphidicolin treatment. Heliquinomycin delayed cell cycle traverse of HeLa S3 cells from S phase to G2 phase in 6 hours and consequently arrested at G2/M phase in 9 hours (Fig. 4B ). 
